Company
Headquarters: Taipei, Taiwan
TW$1.55 Billion
TWD as of July 1, 2024
US$47.5 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Sagittarius Life Science Corp researches and develops plant drugs in Taiwan. The company engages in the development of Chinese herbal medicine technology platform for the treatment of various diseases. It also offers nutritional supplements, health foods, and health related products. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sagittarius Life Science Corp has the following listings and related stock indices.
Stock: TWSE: 3205 wb_incandescent